Peerawaranun, Pimnara
Landier, Jordi
Nosten, Francois H.
Nguyen, Thuy-Nhien
Hien, Tran Tinh
Tripura, Rupam
Peto, Thomas J.
Phommasone, Koukeo
Mayxay, Mayfong
Day, Nicholas P. J.
Dondorp, Arjen
White, Nick
von Seidlein, Lorenz
Mukaka, Mavuto http://orcid.org/0000-0002-5036-6583
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
https://doi.org/10.1186/s12936-019-3062-x
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
https://doi.org/10.1186/s12936-018-2390-6
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
https://doi.org/10.1186/s12936-017-1703-5
The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
https://doi.org/10.1186/s12936-018-2541-9
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
https://doi.org/10.1186/s12936-019-3087-1
Funding for this research was provided by:
Wellcome Trust (101148/Z/13/Z)
Bill and Melinda Gates Foundation (OPP1081420)
Article History
Received: 19 June 2019
Accepted: 8 December 2019
First Online: 18 December 2019
Ethics approval and consent to participate
: The studies were approved by the Cambodian National Ethics Committee for Health Research (0029NECHR, dated04Mar2013), the Institute of Malariology, Parasitology, and Entomology in Ho Chi Minh City (185/HDDD, dated 15May2013), the Institute of Malariology, Parasitology, and Entomology in Quy Nhon (dated 14Oct2013), the Lao National Ethics Committee for Health Research (RefNo0132015/NECHR), the Government of the Lao PDR, and the Oxford Tropical Research Ethics Committee (1015–13, dated29Apr2013). Each participant, or parent/guardian in the case of minors, provided individual, signed, informed consent; illiterate participants provided a fingerprint countersigned by a literate witness (ClinicalTrials.govIdentifier:NCT01872702).
: Not applicable.
: The authors declare that they have no competing interests.